Teresa O, MD, M.Arch, FACS, is a facial plastic and reconstructive surgeon who focuses on the treatment of vascular lesions and/or facial paralysis. Dr. O serves as Director of the New York Facial Paralysis Center. She also has a dual subspecialty focus in hemangiomas and malformations. Her unique background as a licensed Architect (NY) gives her a deeper appreciation of facial aesthetics in 3-D reconstruction. Dr. O has published extensively in scientific journals and textbooks and is double-board-certified in Facial Plastic and Reconstructive Surgery and Otolaryngology-Head and Neck Surgery.

Dr. O matriculated at Cornell University as an architecture student (B.Arch, M.Arch). She later graduated from Boston University Medical School. She completed a residency in Otolaryngology-Head and Neck Surgery at the New York Eye, and Ear Infirmary. She then received fellowship training with Dr. Milton Waner in vascular anomalies. After seeing many patients with the devastating sequelae of facial paralysis, Dr. O pursued further training in facial nerve reanimation with Drs. Hadlock and Cheney at the Massachusetts Eye, and Ear Infirmary in Boston.

Currently, she has restricted her practice to patients with vascular anomalies &/or facial paralysis.  Dr. O is involved in clinical and basic science research and collaborates with labs at the Feinstein Institute, Stonybrook University and Brigham and Women’s Hospital in Boston. She is an Associate Professor at Hofstra University and teaches residents and fellows. She has lectured internationally,and authored or co-authored many peer-reviewed journal articles, and textbook chapters. She has also served as an Editor for textbooks on vascular anomalies and facial paralysis. Dr. O is a member of several major national and international medical associations. She is honored to receive the “Caring for Children” award from the Coalition for Asian American Children and Families (2016), The Little Baby Face Foundation (2014), and Physician of the Year from the Vascular Birthmark Foundation (2018).